Clinical Trial Update: A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a personalized neoantigen cancer vaccine in treatment-naïve, asymptomatic IGHV-unmutated chronic lymphocytic leukemia patients; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lymphocytic Leukemia | Phase 1 | Status: RECRUITING